Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 56, Issue 5, 2001, Pages

  Kenny, A M ^a   Prestwood, K M ^a   Gruman, C A ^a   Marcello, K M ^a   Raisz, L G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; ESTRADIOL; ESTRONE; HEMOGLOBIN; PROCOLLAGEN; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; VITAMIN D;

AGED; ARTICLE; BONE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MALE; MUSCLE; MUSCLE STRENGTH; OSSIFICATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

EID: 0035028887     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/56.5.M266     Document Type: Article

References (38)

1. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men
2. Decreased bioavailable testosterone in aging normal and impotent men
3. Secondary hypogonadism in older men: Its relationship to impotence
4. An examination of research design effects on the association of testosterone and aging: Results of a meta-analysis
5. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study
6. Effects of testosterone supplementation in the aging male
7. Determinants of bone density in healthy older men with low testosterone levels
8. The physical activity scale for the elderly (PASE): Development and evaluation
9. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: Influence of application site: A clinical research center study
10. Exercise training and nutritional supplementation for physical frailty in very elderly people
11. Effect of testosterone treatment on bone mineral density in men over 65 years of age
12. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism
13. Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors
14. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism
15. Effects of intramuscular and transdermal testosterone on bone turnover markers, prostate symptoms, and cholesterol in men over age 70 with low testosterone levels: A pilot study
16. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men: A clinical research center study
17. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
18. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation
19. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
20. Male osteoporosis predictors: Sex hormones and calcitropic hormones
21. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study
22. Sex steroids and bone mass in older men: Positive association with serum estrogens and negative associations with androgens
23. Lack of association between free testosterone and bone density separate from age in elderly males
24. Marked decline in trabecular bone mineral content in healthy men with age: Lack of association with sex steroid levels
25. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial
26. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
27. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception
28. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement
29. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women
30. Functional improvement with vitamin D replenishment in a cohort of frail, vitamin D-deficient older people
31. Myopathy in bone loss of aging: Improvement by treatment with 1alpha-hydroxycholecalciferol and calcium
32. Do vitamin D supplements improve the physical capabilities of elderly hospital patients?
33. 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: A randomized controlled trial
34. Prostatic complications of testosterone replacement therapy
35. Prospective study of sex hormone levels and risk of prostate cancer
36. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
37. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men